Machinery & Materials
Logistics & Cold Chain
More from GBI Research
Big pharma faces serious competition in emerging countries
While the expanding economies and populations of Asia, Africa and Latin America have gained the attention of international pharmaceutical giants, local competition is proving a significant challenge, finds a new report by healthcare industry experts GBI Research.
Sep 11th, 2012
Testing, Testing: Clinical Trials Making the Move to Emerging Countries
In an attempt to save time, money and resources, international pharmaceutical companies are increasingly out-sourcing clinical trials to countries in Asia, Latin America and Eastern Europe, according to a new report by industry experts GBI Research.
Aug 24th, 2012
South and Central America Active Pharmaceutical Ingredients Market Closing Gap on Northern Neighbors
The Active Pharmaceutical Ingredients (API) market in the Americas was worth a staggering $46 billion in 2011, with North America accounting for over 88% of it.
Aug 14th, 2012
Argentina Takes Hold of Public Healthcare
Argentina is boosting the health of their citizens thanks to strong government schemes that are providing medical attention to those that need it, while financially supporting the country's in-house pharmaceutical production, according to a new report from healthcare experts GBI Research.
Jun 22nd, 2012
More Guidelines Needed to Grow Regenerative Medicine Market, Report Finds
Standardized research guidelines are needed to control and encourage the development of gene therapy and stem cell treatments, according to a new report by healthcare experts GBI Research.
Jun 12th, 2012
Contract Manufacturing in India and China Backed by Government Policies
Contract Manufacturing Organizations (CMO) will reap the rewards as pharmaceutical production becomes increasingly globalized, according to a new report by business intelligence experts GBI Research.
May 17th, 2012
Patient Perspectives Influencing Drug Development
Support is growing for increased collaboration between pharmaceutical companies and patients in research processes worldwide, according to a new report by healthcare intelligence company GBI Research.
May 3rd, 2012
Struggling Pharma Companies to Outsource Clinical Trial Research
Falling revenue in some healthcare sectors means companies are making huge efforts to reduce R&D expenditure and increase profitability, and are outsourcing clinical trial activities to Contract Research Organizations (CROs) in order to achieve this, according to a new report by healthcare intelligence company GBI Research.
Apr 24th, 2012
Cloud Computing Comes to Healthcare Sector, But May Drift Over Developed Economies
Improved electronic data systems are eagerly anticipated in hospitals across the world, but their implementation may be balanced on national financial climates, according to a new report by business intelligence experts GBI Research.
Apr 17th, 2012